scholarly article | Q13442814 |
P50 | author | Silvia Colucci | Q37829968 |
Maria Grano | Q37829977 | ||
Giacomina Brunetti | Q40380152 | ||
Maria F. Faienza | Q47504141 | ||
Luciano Cavallo | Q57374836 | ||
P2093 | author name string | Lucia Giordani | |
Giovanni Carlo Del Vecchio | |||
Massimo D'Amore | |||
Maria Ciccarelli | |||
Laura Piacente | |||
Livia Albanese | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2269-2276 | |
P577 | publication date | 2009-04-28 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance. | |
P478 | volume | 94 |
Q43007771 | Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin |
Q57809044 | An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases |
Q46284598 | Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS. |
Q30478264 | Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase |
Q35592362 | Bone-immune cell crosstalk: bone diseases. |
Q38099517 | Causes, mechanisms and management of paediatric osteoporosis |
Q38406386 | Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations |
Q37056309 | Cross-talk between T cells and osteoclasts in bone resorption |
Q57984974 | Evaluation of impact of steroid replacement treatment on bone health in children with 21-hydroxylase deficiency |
Q64118749 | Experience in the Adaptive Immunity Impacts Bone Homeostasis, Remodeling, and Healing |
Q26821908 | Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency |
Q54276622 | High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. |
Q41921500 | Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems. |
Q64119225 | Metabolic Bone Disease of Prematurity: Diagnosis and Management |
Q47638169 | Monoclonal antibodies for treating osteoporosis |
Q41980849 | Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia |
Q27026535 | Osteoporosis and obesity: Role of Wnt pathway in human and murine models |
Q37402046 | Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review |
Q38568957 | Peripheral Blood Mononuclear Cells Spontaneous Osteoclastogenesis: Mechanisms Driving the Process and Clinical Relevance in Skeletal Disease |
Q36914237 | Postmenopausal osteoporosis: the role of immune system cells |
Q34073420 | Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. |
Q35617495 | The "love hormone" oxytocin regulates the loss and gain of the fat-bone relationship |
Q37052226 | The Interplay between the bone and the immune system |
Q53563222 | The evaluation of bone metabolism in children with renal transplantation. |
Q58327145 | Treatment of osteoporosis in children with glucocorticoid-treated diseases |
Search more.